USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: Preliminary results

European Radiology

Volumn 14, Issue 6, 2004, Pages 937-944

  Keller, Thomas M ^a   Michel, Sven C A ^a   Fröhlich, Johannes ^b   Fink, Daniel ^c   Caduff, Rosmarie ^a   Marincek, Borut ^a   Kublik Huch, Rahel A ^d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Guerbet AG   (Switzerland)

^c UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^d Kantonsspital Baden   (Switzerland)

Author keywords

Cervical; Contrast agent agent; Endometrial carcinoma; Lymph node; Lympholography; MRI; Tumors staging; USPIO; Uterus

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; USAN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; FEMALE; FEMALE GENITAL TRACT TUMOR; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; IMAGING SYSTEM; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS TUMOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; UTERUS CARCINOMA; UTERUS TUMOR;

ADULT; AGED; FEASIBILITY STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMAGE ENHANCEMENT; IRON; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; OXIDES; PELVIC NEOPLASMS; POLYGONATUM; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 2942741072     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2258-8     Document Type: Article

References (32)

1. Grigsby PW, Herzog TJ (2001) Current management of patients with invasive cervical carcinoma. Clin Obstet Gynecol 44:531-537
2. Boronow RC, Morrow CP, Creasman WT et al (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825-832
3. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS (1991) Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78:63-69
4. Sevin BU, Nadji M, Lampe B et al (1995) Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 76:1978-1986
5. Buckley SL, Tritz DM, Van Le L et al (1996) Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 63:4-9
6. Shepherd JH (1989) Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96:889-892
7. UICC (2002) TNM Classification of Malignant Tumour. In: Sobin LH, Ch. Wittekind (eds), 6th edn
8. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL (1995) Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86:43-50
9. Kinkel K, Kaji Y, Yu KK et al (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212:711-718
10. Roy C, Le Bras Y, Mangold L et al (1997) Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol 52:437-440
11. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR (1997) Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 278:1096-1101
12. Bellin MF, Roy C, Kinkel K et al (1998) Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 207:799-808
13. Kim SH, Kim SC, Choi BI, Han MC (1994) Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 190:807-811
14. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990) Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494-498
15. Rogers JM, Lewis J, Josephson L (1994) Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227. Magn Reson Imaging 12:1161-1165
16. Anzai Y, Blackwell KE, Hirschowitz SL et al (1994) Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192:709-715
17. Hamm B (2002) Iron-oxide-enhanced MR lymphography: just a new toy or a breakthrough? Eur Radiol 12:957-958
18. Nguyen BC, Stanford W, Thompson BH et al (1999) Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. J Magn Reson Imaging 10:468-473
19. Pannu HK, Wang KP, Borman TL, Bluemke DA (2000) MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging 12:899-904
20. Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ (2002) Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222:239-244
21. Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-Kobrunner SH (2002) Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 16:60-68
22. Michel SC, Keller TM, Frohlich JM et al (2002) Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225:527-536
23. Harisinghani MG, Saini S, Weissleder R et al (1999) MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Am J Roentgenol 172:1347-1351
24. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL (1988) Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166:623-631
25. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N (1991) MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179:829-832
26. Sironi S, Belloni C, Taccagni GL, DelMaschio A (1991) Carcinoma of the cervix: value of MR imaging in detecting parametrial involvement. Am J Roentgenol 156:753-756
27. Sironi S, Colombo E, Villa G et al (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185:207-212
28. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319-2331
29. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA (1995) Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model. Invest Radiol 30:706-711
30. Sigal R, Vogl T, Casselman J et al (2002) Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall super-paramagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 12:1104-1113
31. Bellin MF, Beigelman C, Precetti-Morel S (2000) Iron oxide-enhanced MR lymphography: initial experience. Eur J Radiol 34:257-264
32. Tanoura T, Bernas M, Darkazanli A, et al (1992) MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis. Am J Roentgenol 159:875-881